In the MAPK signaling pathway, the phosphorylation of ERK 1/2 and JNK activates the AP (activator protein)-1 transcription factor family, including c-Fos and c-Jun, and thus promotes the expression of matrix metalloproteinases (MMPs) in cancer cells [19–21]. The gene discussed is MAPK8; the disease is cancer.